Large-scale study uncovers demographic and sex factors behind genetic cause of age-related visual loss
A new study has identified a major genetic contributor to Fuchs’ Endothelial Corneal Dystrophy (FECD), a common cause of vision loss, also highlighting the significant roles of sex and ancestry. FECD is a common, inherited eye condition that primarily affects...
Major survey calls for new ideas on how to reinvent post diagnostic support for blind and partially sighted people
The Royal National Institute of Blind People (RNIB) is launching a new research study to better understand post-diagnostic support across the sight loss sector. People who have experienced being diagnosed with a sight condition know it’s not always easy to...
Novel retinal pigment metric tackles bias in AI models
25 February 2025
|
AI, oculomics, Moorfields, research, equality, retinal pigment score, RPS, UCL, diversity
Researchers have developed an innovative metric for objectively classifying pigmentation in a retinal image, rather than using subjective social constructs like ethnicity or other demographic variables, as is currently the case when building health datasets. Called the Retinal Pigment Score...
Genetic therapy gives infants life-changing improvements in sight
24 February 2025
|
genetics, gene therapy, Moorfields, paediatrics, research, new, AIPL1, Leber Congenital Amaurosis
Four young children have gained life-changing improvements in sight following treatment with a pioneering new genetic medicine through Moorfields Eye Hospital and UCL Institute of Ophthalmology, with the support of MeiraGTx. The children were born with a severe impairment to...
New AI in ophthalmology resource goes live
The Royal College of Ophthalmologists has launched a new free resource, sharing and signposting artificial intelligence as medical device (AIaMD) tools for use in ophthalmology. The online AI directory is an evolving catalogue of AIaMD tools used in research or...
Age and gender impacts effectiveness of new gene therapy treatments for eye diseases, new study finds
14 February 2025
|
research, genetics, gene therapy, pathology, education, Adeno-Associated Virus, inflammation
Older women could be vulnerable to harmful inflammation from new gene therapies to treat incurable eye diseases, new research has found. The University of Bristol-led study, published in Molecular Therapy, reveal how age and gender affects inflammation caused by gene...
New online tool will be a critical planning resource for commissioners and providers of eye health care
Eye disease is a major contributor to national health service backlogs, and the number of cases is set to significantly increase with an ageing population. Organisations from across the UK’s eye care sector, including the Association of British Dispensing Opticians...
Study finds telemedicine improves care for children with eye cancer
Orbis announces new research that finds telemedicine can improve care for children with retinoblastoma, a form of childhood cancer that can lead to blindness. The study, published in JCO Global Oncology, is the first to show that virtual mentor-mentee relationships...
World-class centre for eye health reaches construction milestone
The new home for Moorfields Eye Hospital NHS Foundation Trust and the UCL Institute of Ophthalmology reached a significant construction milestone today. The completion of the concrete structure as part of the new centre for advancing eye health in St...
Glaucoma UK launches new research grant programme to support innovative glaucoma research
Glaucoma UK is thrilled to announce the launch of its reshaped research programme for 2025 to support innovative research to improve the understanding, treatment, and care of glaucoma. The charity is committed to funding the most promising researchers and proposals...
District hospitals key to unlocking Global South surgical conundrum
Patients attending first referral hospitals in low- and middle-income countries (LMICs) receive surgical care that is just as safe and effective as that provided by higher level referral centres, a new study reveals. Researchers found no significant difference in 30-day...
Ciliatech appoints world-class panel of eyecare specialists to newly created KOL advisory board
Ciliatech will leverage ophthalmic expertise of seven-member advisory board to bring to market Intercil® Uveal Spacer, a novel glaucoma implant offering unique benefits to eye surgeons and patients across the globe Ciliatech, an innovative medtech company focusing on the treatment...
